Nephera Raises $2.85 Million

Nephera, an Israeli developer of medival devices for patients suffering from congestive heart failure, has raised $2.85 million in second-round funding. Backers include Aurum Ventures, Evergreen Venture Partners and the Trendlines Group.

12 August 2010•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail